Informazioni sui membri
Dr Laura Mauring
Sostituire
Estonia
Gruppi di lavoro: Malattie rare dell'occhio della retina (WG1), Malattie rare dell'oftalmologia pediatrica (WG3), Diagnostica genetica (TWG6)
Team
Centro HCP
L'Ospedale Universitario di Tartu è il più grande fornitore di assistenza sanitaria in Estonia. L'assistenza medica terziaria di alta qualità è offerta in quasi tutti...
contatti
Test clinici
NCT04435366 Completato
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
interventistica
NCT04423718 Attivo, non reclutante
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
interventistica
NCT04270747 Completato
A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration
interventistica
NCT04939571 Reclutamento, attivo
European Disease Registry on Retinopathy of Prematurity (ROP)
osservazionale